Literature DB >> 6881430

Persistence of cholera in the United States.

W X Shandera, B Hafkin, D L Martin, J P Taylor, D L Maserang, J G Wells, M Kelly, K Ghandi, J B Kaper, J V Lee, P A Blake.   

Abstract

In 1973, 1978, and 1981, cases of cholera were acquired along the Gulf Coast of the United States. The isolates from all of the cases were toxigenic Vibrio cholerae O-group 1, biotype El Tor, serotype Inaba, hemolytic, and of the same phage sensitivity pattern, and all had the same restriction endonuclease pattern by molecular genetic analysis. The strain from one of the two 1981 cases differed from the others in having a small plasmid and a negative Voges-Proskauer reaction. Multiple importations, chronic carriers, and continuous occurrence of undetected cases are unlikely explanations for these findings, which suggest that toxigenic V. cholerae 01 can multiply and persist for years in some environments, making eradication of cholera a formidable task.

Entities:  

Mesh:

Year:  1983        PMID: 6881430     DOI: 10.4269/ajtmh.1983.32.812

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

1.  Genetic diversity among toxigenic and nontoxigenic Vibrio cholerae O1 isolated from the Western Hemisphere.

Authors:  F Chen; G M Evins; W L Cook; R Almeida; N Hargrett-Bean; K Wachsmuth
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

Review 2.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 3.  The human pathogenic vibrios--a public health update with environmental perspectives.

Authors:  P A West
Journal:  Epidemiol Infect       Date:  1989-08       Impact factor: 2.451

4.  Molecular epidemiology of non-O1 Vibrio cholerae and Vibrio mimicus in the U.S. Gulf Coast region.

Authors:  J B Kaper; J P Nataro; N C Roberts; R J Siebeling; H B Bradford
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

Review 5.  Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp.

Authors:  J M Janda; C Powers; R G Bryant; S L Abbott
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

6.  Detection of Vibrio cholerae with monoclonal antibodies specific for serovar O1 lipopolysaccharide.

Authors:  L B Adams; M C Henk; R J Siebeling
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

7.  Molecular evolution of the seventh-pandemic clone of Vibrio cholerae and its relationship to other pandemic and epidemic V. cholerae isolates.

Authors:  D K Karaolis; R Lan; P R Reeves
Journal:  J Bacteriol       Date:  1994-10       Impact factor: 3.490

Review 8.  Infectious diseases associated with molluscan shellfish consumption.

Authors:  S R Rippey
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

9.  Persistence of cholera in the United States: isolation of Vibrio cholerae O1 from a patient with diarrhea in Maryland.

Authors:  F Y Lin; J G Morris; J B Kaper; T Gross; J Michalski; C Morrison; J P Libonati; E Israel
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

Review 10.  Reviving the "Moore Swab": a Classic Environmental Surveillance Tool Involving Filtration of Flowing Surface Water and Sewage Water To Recover Typhoidal Salmonella Bacteria.

Authors:  Michael J Sikorski; Myron M Levine
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.